Skip to content

Public FDA record

Z-2271-2018: Cryovalve(R) SG Pulmonary Human Heart Valve, Catalog Number SGPVVOO

Recall record Z-2271-2018 for CryoLife, Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-2271-2018
Company in FDA record
CryoLife, Inc.
FDA record creation date
Jun 21, 2018
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Devices, which met FDA and AATB eligibility criteria, were distributed. Final autopsy and toxicology reports indicated the presence of morphine in the urine.

Source facts

Action
The firm notified the consignees by letter on 05/14/2018.
Initiated
2018-05-14
Root cause
Under Investigation by firm
Terminated
2019-03-29
Distribution
AR, OH
Recall number
Z-2271-2018
Recall status
Terminated
CDRH record ID
164840
FDA record created
2018-06-21
Recall event number
80199

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗